Evidence map›Paper›PMID 31164467›Full record

ArticlemBio2019

Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal

Olivia A Todd, Paul L Fidel, Janette M Harro, Jamese J Hilliard, Christine Tkaczyk, Bret R Sellman, Mairi C Noverr, Brian M Peters

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 101 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. The metabolic trap:Journal of medical microbiology · 2026
    Article
  6. Article
  7. Review
  8. Copper-driven mutualism ofMicrobiology (Reading, England) · 2026
    Article
  9. Secreted factors ofApplied and environmental microbiology · 2026
    Article
  10. Journal of bacteriology · 2026
    Article
  11. Article
  12. Review
  13. Differences in Clinical Characteristics of AECOPD Patients with or withoutInternational journal of chronic obstructive pulmonary disease · 2026
    Article
  14. Article
  15. Synergistic interactions betweenProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. [The role ofLin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Olivia A ToddIntegrated Program in Biomedical Sciences, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Paul L FidelDepartment of Oral Biology, School of Dentistry, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Janette M HarroDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland-Baltimore, Baltimore, Maryland, USA.
Jamese J HilliardDepartment of Microbial Sciences, AstraZeneca, Gaithersburg, Maryland, USA.
Christine TkaczykDepartment of Microbial Sciences, AstraZeneca, Gaithersburg, Maryland, USA.
Bret R SellmanDepartment of Microbial Sciences, AstraZeneca, Gaithersburg, Maryland, USA.
Mairi C Noverr *Department of Oral Biology, School of Dentistry, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Brian M Peters *Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA brian.peters@uthsc.edu.
AstraZeneca (United States) · USUniversity of Tennessee Health Science Center · USLouisiana State University Health Sciences Center New Orleans · USTulane University · USUniversity of Maryland, Baltimore · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
Candidalysin: a key mediator of Candida vaginitis immunopathologyR01AI134796 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Brian M Peters · 2018 to 2026
$2.9M
Host and microbial factors promoting synergistic mortality during polymicrobial intra-abdominal infections with Candida albicans and Staphylococcus aureusR01AI116025 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI NOVERR, MAIRI C · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI116025NIAID NIH HHS R01 AI134796NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Quorum SensingAnimalsBacterial ProteinsBacterial ToxinsCandida albicansCandidiasisCoinfectionGastrointestinal DiseasesHemolysin ProteinsMiceMicrobial InteractionsStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsVirulenceVirulence FactorsAgr protein, Staphylococcus aureusBacterial ProteinsBacterial ToxinsHemolysin Proteinsstaphylococcal alpha-toxinTrans-ActivatorsVirulence FactorsCandida albicansintraabdominal infectionpolymicrobial

Identifiers

PMID31164467
PMCPMC6550526
OpenAlexW2948576811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.